InvestorsHub Logo
Followers 4
Posts 1483
Boards Moderated 0
Alias Born 12/11/2013

Re: tilator post# 30606

Friday, 10/13/2017 8:26:18 AM

Friday, October 13, 2017 8:26:18 AM

Post# of 38634
Agreed. it's the Tricky. I'm trying now some adjustment ...I get confused myself, but the split by manufacturer name does not show the split amont drug name/type.

Yearly 2016

Quetiapine Fumarate 5.8Bln
Quetiapine Fumarate ER 81.1Mln
Seroquel XR 1.27Bln
Seroquel 119.3Mln


So we should just pick the Seroquel XR (I believe)

YTD
Quetiapine Fumarate 4.87Bln
Quetiapine Fumarate ER 430.9Mln
Seroquel XR 299.8Mln
Seroquel 26.0Mln


Weekly TOTAL Sales of Seroquel XR (week ended 06/10/2017) = 6.26Mln

Mallinckrodt Sales (under the Whole category QUETIAPINE FUMARATE Molecule)(week ended 06/10/2017) = 526K

If we assume Mallinck sales are just Seroquel XR (could be confirmed by the fact that first sales shown are in june17, precisely 2.2K in the first week ended 06/16/17)

then market share based on last weekly data is

526K/6.26Mln = 8.40%


there are a multitude of data, filters, etc
If someone can reed through them under PRICING, by manufacturer, I found this:

Mallinckrodt:
400 MG Sustained Rel Tab Package:60 WAC Unit: 1.15 WAC Pkg:69
200 MG Sustained Rel Tab Package:60 WAC Unit: 0.88 WAC Pkg:53
50 MG Sustained Rel Tab Package:60 WAC Unit: 0.71 WAC Pkg:42.56
150 MG Sustained Rel Tab Package:60 WAC Unit: 0.78 WAC Pkg:47
300 MG Sustained Rel Tab Package:60 WAC Unit: 1.02 WAC Pkg:61

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPCI News